{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:25:06Z","timestamp":1786991106984,"version":"build-2736575974"},"reference-count":16,"publisher":"Society of Nuclear Medicine","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.2967\/jnumed.121.263768","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T19:40:14Z","timestamp":1659123614000},"page":"232-238","source":"Crossref","is-referenced-by-count":10,"title":["<sup>68<\/sup>Ga-DOTATATE Prepared from Cyclotron-Produced<sup>68<\/sup>Ga: An Integrated Solution from Cyclotron Vault to Safety Assessment and Diagnostic Efficacy in Neuroendocrine Cancer Patients"],"prefix":"10.2967","volume":"64","author":[{"given":"S\u00e9bastien","family":"Tremblay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oph\u00e9lie","family":"B\u00e9lissant Benesty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Ait-Mohand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Dumulon-Perreault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9tienne","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric E.","family":"Turcotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Gu\u00e9rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"2023031310500859000_64.2.232.1","first-page":"1059","article-title":"The shortage of approved 68Ge\/68Ga generators: incoming material inspection and GMP compliant use of non-approved generators [abstract]","volume":"60","author":"Mueller","year":"2019","journal-title":"J Nucl Med."},{"key":"2023031310500859000_64.2.232.2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nucmedbio.2019.03.002","article-title":"Cyclotron production of 68Ga in a liquid target: effects of solution composition and irradiation parameters","volume":"74\u201375","author":"Pandey","year":"2019","journal-title":"Nucl Med Biol."},{"key":"2023031310500859000_64.2.232.3","first-page":"10.1063\/1.4983532","article-title":"Cyclotron production of Ga-68 for human use from liquid targets: from theory to practice","volume":"1845","author":"Alves","year":"2017","journal-title":"AIP Conf Proc."},{"key":"2023031310500859000_64.2.232.4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s41181-020-00106-9","article-title":"Cyclotron-based production of 68Ga, [68Ga]GaCl3, and [68Ga]Ga-PSMA-11 from a liquid target","volume":"5","author":"Rodnick","year":"2020","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2023031310500859000_64.2.232.5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apradiso.2017.12.010","article-title":"Production of curie quantities of 68Ga with a medical cyclotron via the 68Zn(p,n)68Ga reaction","volume":"133","author":"Lin","year":"2018","journal-title":"Appl Radiat Isot."},{"key":"2023031310500859000_64.2.232.6","doi-asserted-by":"crossref","first-page":"109014","DOI":"10.1016\/j.apradiso.2019.109014","article-title":"Automated radiosynthesis of 68Ga for large-scale routine production using 68Zn pressed target","volume":"156","author":"Alnahwi","year":"2020","journal-title":"Appl Radiat Isot."},{"key":"2023031310500859000_64.2.232.7","first-page":"25","article-title":"Cyclotron production of 68Ga via proton-induced reaction on 68Zn target","volume":"54","author":"Sadeghi","year":"2009","journal-title":"Nukleonika."},{"key":"2023031310500859000_64.2.232.8","unstructured":"International Atomic Energy Agency. Gallium-68 Cyclotron Production. IAEA; 2019. TECDOC-1863."},{"key":"2023031310500859000_64.2.232.9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nucmedbio.2019.07.005","article-title":"Rapid and automated production of [68Ga]gallium chloride and [68Ga]Ga-DOTA-TATE on a medical cyclotron","volume":"74\u201375","author":"Tieu","year":"2019","journal-title":"Nucl Med Biol."},{"key":"2023031310500859000_64.2.232.10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.nucmedbio.2020.01.005","article-title":"Taking cyclotron 68Ga production to the next level: expeditious solid target production of 68Ga for preparation of radiotracers","volume":"80\u201381","author":"Nelson","year":"2020","journal-title":"Nucl Med Biol."},{"key":"2023031310500859000_64.2.232.11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41181-020-00114-9","article-title":"Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE","volume":"6","author":"Thisgaard","year":"2021","journal-title":"EJNMMI Radiopharm Chem."},{"key":"2023031310500859000_64.2.232.12","first-page":"1271","article-title":"89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies","volume":"44","author":"Verel","year":"2003","journal-title":"J Nucl Med."},{"key":"2023031310500859000_64.2.232.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.nimb.2010.02.091"},{"key":"2023031310500859000_64.2.232.14","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0969-8043(97)10103-8","article-title":"Evaluated cross section and thick target yield data of Zn+P processes for practical applications Private communication","volume":"49","author":"Szelecs\u00e9nyi","year":"1997","journal-title":"Appl Radiat Isot."},{"key":"2023031310500859000_64.2.232.15","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100541"},{"key":"2023031310500859000_64.2.232.16","unstructured":"Gallium (68Ga) chloride (accelerator produced) solution for radiolabelling. In: European Pharmacopoeia. Council of Europe; 2020:4864\u20134865."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.263768","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T17:53:25Z","timestamp":1678730005000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.263768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2,1]]},"published-print":{"date-parts":[[2023,2]]}},"alternative-id":["10.2967\/jnumed.121.263768"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.263768","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}